In Vitro Evaluation of Probiotic Properties of Two Novel Probiotic Mixtures, Consti- Biome and Sensi-Biome
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Changes in the gut microbiome cause recolonization by pathogens and inflammatory responses, leading to the development of intestinal disorders. Probiotics administration has been proposed for many years to reverse the intestinal dysbiosis and to enhance intestinal health. This study aimed to evaluate the inhibitory effects of two newly designed probiotic mixtures, Consti-Biome and SensiBiome, on two enteric pathogens Staphylococcus aureus and Escherichia coli that may cause intestinal disorders. Additionally, the study was designed to evaluate whether Consti-Biome and Sensi-Biome could modulate the immune response, produce short-chain fatty acids (SCFAs), and reduce gas production. Consti-Biome and Sensi-Biome showed superior adhesion ratios to HT-29 cells and competitively suppressed pathogen adhesion. Moreover, the probiotic mixtures decreased the levels of pro-inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-6 and IL1β. Cell-free supernatants (CFSs) were used to investigate the inhibitory effects of metabolites on growth and biofilms of pathogens. Consti-Biome and Sensi-Biome CFSs exhibited antimicrobial and anti-biofilm activity, where microscopic analysis confirmed an increase in the number of dead cells and the structural disruption of pathogens. Gas chromatographic analysis of the CFSs revealed their ability to produce SCFAs, including acetic, propionic, and butyric acid. SCFA secretion by probiotics may demonstrate their potential activities against pathogens and gut inflammation. In terms of intestinal symptoms regarding abdominal bloating and discomfort, Consti-Biome and Sensi-Biome also inhibited gas production. Thus, these two probiotic mixtures have great potential to be developed as dietary supplements to alleviate the intestinal disorders.
Abstract
Changes in the gut microbiome cause recolonization by pathogens and inflammatory responses, leading to the development of intestinal disorders. Probiotics administration has been proposed for many years to reverse the intestinal dysbiosis and to enhance intestinal health. This study aimed to evaluate the inhibitory effects of two newly designed probiotic mixtures, Consti-Biome and SensiBiome, on two enteric pathogens Staphylococcus aureus and Escherichia coli that may cause intestinal disorders. Additionally, the study was designed to evaluate whether Consti-Biome and Sensi-Biome could modulate the immune response, produce short-chain fatty acids (SCFAs), and reduce gas production. Consti-Biome and Sensi-Biome showed superior adhesion ratios to HT-29 cells and competitively suppressed pathogen adhesion. Moreover, the probiotic mixtures decreased the levels of pro-inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-6 and IL1β. Cell-free supernatants (CFSs) were used to investigate the inhibitory effects of metabolites on growth and biofilms of pathogens. Consti-Biome and Sensi-Biome CFSs exhibited antimicrobial and anti-biofilm activity, where microscopic analysis confirmed an increase in the number of dead cells and the structural disruption of pathogens. Gas chromatographic analysis of the CFSs revealed their ability to produce SCFAs, including acetic, propionic, and butyric acid. SCFA secretion by probiotics may demonstrate their potential activities against pathogens and gut inflammation. In terms of intestinal symptoms regarding abdominal bloating and discomfort, Consti-Biome and Sensi-Biome also inhibited gas production. Thus, these two probiotic mixtures have great potential to be developed as dietary supplements to alleviate the intestinal disorders.
참고문헌 (54)
- Hill C, "The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic", Nat. Rev. Gastroenterol. Hepatol, 11, pp.506~514 (2014)
- Tassell ML Van, "Lactobacillus adhesion to mucus", Nutrients, 3, pp.613~636 (2011)
- Rolfe RD, "The role of probiotic cultures in the control of gastrointestinal health", J. Nutr, 130, pp.396~402 (2000)
- Collado MC, "Adhesion and aggregation properties of probiotic and pathogen strains", Eur. Food Res. Technol, 226, pp.1065~1073 (2008)
- Hosseini A, "Probiotics use to treat irritable bowel syndrome", Expert Opin. Biol. Ther, 12, pp.1323~1334 (2012)
- Jang YJ, "Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota", Gut Microbes, 10, pp.696~711 (2019)
- Chapman CMC, "Health benefits of probiotics: are mixtures more effective than single strains?", Eur. J. Nutr, 50, pp.1~17 (2011)
- Candela M, "Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8production", Int. J. Food Microbiol, 125, pp.286~292 (2008)
- Thananimit S, "Characterization of short chain fatty acids produced by selected potential probiotic Lactobacillus strains", Biomolecules, 12, pp.1829~ (2022)
- Akhtar M, "Short chain fatty acids (SCFAs) are the potential immunomodulatory metabolites in controlling Staphylococcus aureus-mediated mastitis", Nutrients, 14, pp.3687~ (2022)
- Shavakhi A, "The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: a randomized placebo-controlled trial", Adv. Biomed. Res, 3, pp.139~ (2014)
- Kwoji ID, "Multi-strain probiotics: synergy among isolates enhances biological activities", Biology (Basel), 10, pp.1~20 (2021)
- 김민국, "Prebiotics", Probiotics Mixture Induced Changes in Cecal Microbiome and Intestinal Morphology Alleviated the Loperamide-Induced Constipation in Rat, 2021, pp.41(3), 527~541[DOI]
- Mezzasalma V, "A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation", Biomed Res. Int, 2016, pp.4740907~ (2016)
- Martoni CJ, "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial", Nutrients, 12, pp.363~ (2020)
- Ohkusa T, "Gut microbiota and chronic constipation: a review and update", Front. Med, 6, pp.19~ (2019)
- Zhao S, "Aberrantly expressed genes and miRNAs in slow transit constipation based on RNAseq analysis", Biomed Res. Int, 2018, pp.2617432~ (2018)
- Duboc H, "Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome", Neurogastroenterol. Motil, 24, pp.513~520 (2012)
- Li Y, "Gut microbiota and diarrhea: an updated review", Front. Cell. Infect. Microbiol, 11, pp.625210~ (2021)
- Wang T, "Lactobacillus reuteri HCM2 protects mice against enterotoxigenic Escherichia coli through modulation of gut microbiota", Sci. Rep, 8, pp.17485~ (2018)
- Noh Hye-Ji, "Immunostimulatory Effect of Heat-Killed Probiotics on RAW264.7 Macrophages", Journal of Microbiology and Biotechnology, 32(5), pp.638~644 (2022), 한국미생물·생명공학회[DOI]
- Lee J, "Immunostimulatory activity of lactic acid bacteria cell-free supernatants through the activation of NF-κB and MAPK signaling pathways in RAW 264.7 cells", Microorganisms, 10, pp.2247~ (2022)
- Kimelman H, "Probiotic bifunctionality of Bacillus subtilis—rescuing lactic acid bacteria from desiccation and antagonizing pathogenic Staphylococcus aureus", Microorganisms, 7, pp.407~ (2019)
- Monteiro CRAV, "In vitro antimicrobial activity and probiotic potential of Bifidobacterium and Lactobacillus against species of Clostridium", Nutrients, 11, pp.448~ (2019)
- Rajoka MSR, "Isolation and evaluation of probiotic potential of lactic acid bacteria isolated from poultry intestine", Microbiology, 87, pp.116~126 (2018)
- Yu X, "A comparative characterization of different host-sourced Lactobacillus ruminis strains and their adhesive, inhibitory, and immunomodulating functions", Front. Microbiol, 8, pp.657~ (2017)
- Tripathi S, "Ginger extract inhibits LPS induced macrophage activation and function", BMC Complement. Altern. Med, 8, pp.1~ (2008)
- Pieniz S, "Probiotic potential, antimicrobial and antioxidant activities of Enterococcus durans strain LAB18s", Food Control, 37, pp.251~256 (2014)
- 장혜지, "Lactobacillus plantarum G72 Showing Production of Folate and Short-chain Fatty Acids", 한국미생물·생명공학회지, 49(1), pp.18~23 (2021), 한국미생물·생명공학회[DOI]
- Anderson JG, "Gas production by Escherichia coli in selective lactose fermentation media", FEMS Microbiol. Lett, 8, pp.17~21 (1980)
- Olvera-Rosales LB, "Impact of the gut microbiota balance on the health-disease relationship: the importance of consuming probiotics and prebiotics", Foods, 10, pp.1261~ (2021)
- Gibson MK, "The Yin and Yang of bacterial resilience in the human gut microbiota", J. Mol. Biol, 426, pp.3866~3876 (2014)
- Dembélé T, "Inhibition of bacterial pathogens by Lactobacilli", Zentralblatt fur Bakteriol, 288, pp.395~401 (1998)
- Servin AL, "Antagonistic activities of Lactobacilli and Bifidobacteria against microbial pathogens", FEMS Microbiol. Rev, 28, pp.405~440 (2004)
- Malfa P, "Evaluation of antimicrobial, antiadhesive and co-aggregation activity of a multi-strain probiotic composition against different urogenital pathogens", Int. J. Mol. Sci, 24, pp.1323~ (2023)
- Pan Y, "The preventive effect of Lactobacillus plantarum ZS62 on DSS-induced IBD by regulating oxidative stress and the immune response", Oxid. Med. Cell. Longev, 2021, pp.9416794~ (2021)
- 한경준, "Antioxidant and Anti-Inflammatory Effect of Probiotic Lactobacillus plantarum KU15149 Derived from Korean Homemade Diced-Radish Kimchi", Journal of Microbiology and Biotechnology, 30(4), pp.591~598 (2020), 한국미생물·생명공학회[DOI]
- Lu J, "Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis", Gastroenterology, 125, pp.1785~1795 (2003)
- Mirsepasi-Lauridsen HC, "Secretion of alpha-hemolysin by Escherichia coli disrupts tight junctions in ulcerative colitis patients", Clin. Transl. Gastroenterol, 7, pp.E149~ (2016)
- Mirsepasi-Lauridsen HC, "Escherichia coli pathobionts associated with inflammatory bowel disease", Clin. Microbiol. Rev, 32, pp.e00060-18~ (2019)
- Presti I, "Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect", Appl. Microbiol. Biotechnol, 99, pp.5613~5626 (2015)
- Vemuri R, "A human origin strain Lactobacillus acidophilus DDS-1 exhibits superior in vitro probiotic efficacy in comparison to plant or dairy origin probiotics", Int. J. Med. Sci, 15, pp.840~848 (2018)
- Papadimitriou K, "Discovering probiotic microorganisms:in vitro, in vivo, genetic and omics approaches", Front. Microbiol, 6, pp.58~ (2015)
- Han SK, "Lactobacillus rhamnosus HDB1258 modulates gut microbiotamediated immune response in mice with or without lipopolysaccharide-induced systemic inflammation", BMC Microbiol, 21, pp.146~ (2021)
- Hamann L, "Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms", Infect. Immun, 73, pp.193~200 (2005)
- Jones SE, "Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors", BMC Microbiol, 9, pp.35~ (2009)
- Wang G, "Antibacterial effect of cell-free supernatant from Lactobacillus pentosus L-36 against Staphylococcus aureus from bovine mastitis", Molecules, 27, pp.7627~ (2022)
- Gueimonde M, "Lactic Acid Bacteria", pp.285~329 (2011), CRC Press
- Ratajczak W, "Immunomodulatory potential of gut microbiomederived short-chain fatty acids (SCFAs)", Acta Biochim. Pol, 66, pp.1~12 (2019)
- Alva-Murillo N, "Short chain fatty acids (propionic and hexanoic) decrease Staphylococcus aureus internalization into bovine mammary epithelial cells and modulate antimicrobial peptide expression", Vet. Microbiol, 155, pp.324~331 (2012)
- Wei Z, "Sodium acetate inhibits Staphylococcus aureus internalization into bovine mammary epithelial cells by inhibiting NF-κB activation", Microb. Pathog, 107, pp.116~121 (2017)
- Zhang S, "Short chain fatty acids modulate the growth and virulence of pathosymbiont Escherichia coli and host response", Antibiotics, 9, pp.462~ (2020)
- Lasa J, "Comparison of abdominal bloating severity between irritable bowel syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test", Rev. Gastroenterol. Mex, 77, pp.53~57 (2012)
- Kužela L, "Small intestinal bacterial overgrowth syndrome", Gastroenterol. Hepatol, 69, pp.70~72 (2015)
